http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2478383-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11583ee36c0626fabc843f0ba4ed20c8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
filingDate 2008-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_658ef2c459aca0d54e903accfa54e7f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a879650e3680b9aceb8b51f6f2bc6a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c44441cc91507e6c291b23eaabe830ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_493478a1b2a81a0fd22ff5a62e022c4d
publicationDate 2013-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2478383-C2
titleOfInvention Ionophoretic delivery of rotigotine for treatment of parkinson disease
abstract FIELD: medicine, pharmaceutics. n SUBSTANCE: group of inventions relates to medicine and deals with application of composition, which includes rotigotine in concentration, sufficient for providing flow of rotigotine, necessary for obtaining therapeutic effect, and, at least one chloride salt in concentration from 1 to 140 mmol/l, where said composition has pH from 4 to 6.5, for charging device for ionophoresis for treatment of Parkinson disease. n EFFECT: group of inventions provides flow of rotigotine through stratum comeum of humans, which is higher than flow, earlier obtained with application of conventional systems of passive diffusion. n 9 cl, 3 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2717542-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2717542-C9
priorityDate 2002-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2326630-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453882284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553698
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503752
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28864
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454276626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415728876
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451197127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451149986

Total number of triples: 51.